SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AMLN (DIABETES DRUGS) -- Ignore unavailable to you. Want to Upgrade?

To: JFitnich who wrote (1345)5/4/1998 3:46:00 PM
From: MulhollandDrive  Respond to of 2173
 
Well, we're all speculating on this volume. But obviously somebody likes AMLN at these prices, big time. It's pulling back some now, which is to be expected. Very strong resistance at the 6 dollar level.



To: JFitnich who wrote (1345)5/4/1998 6:52:00 PM
From: D.Right  Read Replies (2) | Respond to of 2173
 
SMTG was different where LLY had control of the clinical trials. Once LLY pulled out, the main trial stopped. For AMLN, it is different. JNJ had no part in the trials other than write a check. If AMLN can get a new partner here, everything is back on track.

D.Right


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News